- Home
- QLGN vs ELAB Comparison
QLGN vs ELAB Comparison
Compare QLGN & ELAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QLGN
- ELAB
- Stock Information
- Founded
- QLGN 1996
- ELAB 2020
- Country
- QLGN United States
- ELAB United States
- Employees
- QLGN N/A
- ELAB N/A
- Industry
- QLGN Biotechnology: Pharmaceutical Preparations
- ELAB
- Sector
- QLGN Health Care
- ELAB
- Exchange
- QLGN Nasdaq
- ELAB Nasdaq
- Market Cap
- QLGN 3.1M
- ELAB 3.2M
- IPO Year
- QLGN N/A
- ELAB 2023
- Fundamental
- Price
- QLGN $1.70
- ELAB $4.45
- Analyst Decision
- QLGN
- ELAB
- Analyst Count
- QLGN 0
- ELAB 0
- Target Price
- QLGN N/A
- ELAB N/A
- AVG Volume (30 Days)
- QLGN 43.3K
- ELAB 2.3M
- Earning Date
- QLGN 08-14-2025
- ELAB 08-13-2025
- Dividend Yield
- QLGN N/A
- ELAB N/A
- EPS Growth
- QLGN N/A
- ELAB N/A
- EPS
- QLGN N/A
- ELAB N/A
- Revenue
- QLGN N/A
- ELAB N/A
- Revenue This Year
- QLGN N/A
- ELAB N/A
- Revenue Next Year
- QLGN N/A
- ELAB N/A
- P/E Ratio
- QLGN N/A
- ELAB N/A
- Revenue Growth
- QLGN N/A
- ELAB N/A
- 52 Week Low
- QLGN $1.61
- ELAB $4.31
- 52 Week High
- QLGN $10.45
- ELAB $1,842.11
- Technical
- Relative Strength Index (RSI)
- QLGN 30.88
- ELAB 31.00
- Support Level
- QLGN $1.66
- ELAB $4.31
- Resistance Level
- QLGN $1.77
- ELAB $5.42
- Average True Range (ATR)
- QLGN 0.08
- ELAB 0.97
- MACD
- QLGN 0.04
- ELAB -0.25
- Stochastic Oscillator
- QLGN 12.77
- ELAB 1.98
About QLGN Qualigen Therapeutics Inc.
Qualigen Therapeutics Inc is an early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's program, QN-302, is an investigational small-molecule G-quadruplexes (G4)-selective transcription inhibitor with binding affinity to G4s prevalent in cancer cells.
About ELAB Elevai Labs Inc.
PMGC Holdings Inc advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.